NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Index- P/E- EPS (ttm)-2.24 Insider Own30.27% Shs Outstand3.26M Perf Week5.99%
Market Cap6.00M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.27M Perf Month12.88%
Enterprise Value9.10M PEG- EPS next Q- Inst Own1.04% Short Float2.19% Perf Quarter-26.46%
Income-4.57M P/S1.40 EPS this Y- Inst Trans101.11% Short Ratio0.43 Perf Half Y-7.07%
Sales4.30M P/B0.84 EPS next Y- ROA-29.86% Short Interest0.05M Perf YTD-20.86%
Book/sh2.19 P/C14.63 EPS next 5Y- ROE-59.14% 52W High3.35 -45.07% Perf Year-25.66%
Cash/sh0.13 P/FCF- EPS past 3/5Y58.09% 59.12% ROIC-53.45% 52W Low1.20 53.33% Perf 3Y-98.29%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-22.27% -16.15% Gross Margin-54.47% Volatility7.64% 10.99% Perf 5Y-99.44%
Dividend TTM- EV/Sales2.12 EPS Y/Y TTM71.37% Oper. Margin-103.17% ATR (14)0.20 Perf 10Y-98.92%
Dividend Ex-Date- Quick Ratio0.17 Sales Y/Y TTM-33.10% Profit Margin-106.30% RSI (14)52.77 Recom-
Dividend Gr. 3/5Y- - Current Ratio0.56 EPS Q/Q66.91% SMA208.03% Beta0.88 Target Price-
Payout- Debt/Eq0.49 Sales Q/Q-17.05% SMA50-1.77% Rel Volume0.18 Prev Close1.75
Employees231 LT Debt/Eq0.19 Earnings- SMA200-12.21% Avg Volume116.34K Price1.84
IPOApr 17, 2002 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume20,953 Change5.44%
Date Action Analyst Rating Change Price Target Change
Jan-08-10Initiated Rodman & Renshaw Mkt Outperform $6
Apr-04-25 04:05PM
Dec-18-24 08:30AM
Dec-13-24 08:00AM
Aug-19-24 08:00AM
Feb-23-24 04:05PM
08:00AM Loading…
Nov-29-23 08:00AM
Aug-23-23 07:34PM
Aug-09-23 08:30AM
Feb-24-23 04:05PM
Dec-28-22 08:00AM
Dec-15-22 08:00AM
Dec-05-22 08:00AM
Dec-02-22 04:10PM
Oct-01-22 10:05PM
Jul-18-22 08:00AM
05:00PM Loading…
Jun-22-22 05:00PM
Mar-31-22 08:00AM
Nov-12-21 04:30PM
Aug-13-21 04:30PM
Aug-05-21 09:00AM
Jun-09-21 08:00AM
May-14-21 04:30PM
Apr-19-21 08:30AM
Mar-26-21 05:00PM
Nov-13-20 04:10PM
Oct-11-20 09:23AM
Sep-21-20 08:30AM
Aug-14-20 06:30AM
Aug-11-20 10:10AM
Jun-04-20 07:59PM
06:30AM Loading…
May-15-20 06:30AM
Apr-15-20 08:00AM
Apr-14-20 04:30PM
07:10AM
Apr-05-20 01:17AM
Mar-31-20 06:30AM
Mar-13-20 08:30AM
Mar-02-20 07:00AM
Dec-31-19 08:01AM
Nov-15-19 08:00AM
Oct-28-19 07:39AM
Sep-13-19 07:17AM
Sep-11-19 08:00AM
Sep-06-19 08:31AM
Aug-15-19 06:30AM
May-21-19 07:56PM
May-15-19 06:00AM
May-07-19 08:00AM
Mar-29-19 06:00AM
Jan-08-19 12:58PM
Nov-23-18 08:55AM
Nov-15-18 06:00AM
Nov-13-18 08:00AM
Nov-12-18 08:00AM
Oct-10-18 06:44PM
Aug-15-18 06:00AM
Aug-06-18 08:45AM
May-15-18 08:00AM
06:00AM
May-08-18 08:00AM
Apr-06-18 07:40AM
Apr-05-18 07:10AM
Apr-03-18 06:00AM
Mar-22-18 08:00AM
Dec-01-17 07:58AM
Nov-15-17 06:00AM
Nov-08-17 12:20PM
Nov-07-17 08:00AM
Oct-24-17 03:48PM
Sep-26-17 12:03PM
Sep-14-17 07:40AM
Sep-12-17 04:05PM
Aug-16-17 10:08AM
Aug-15-17 06:00AM
Aug-08-17 06:00AM
May-24-17 09:18AM
May-17-17 08:30AM
May-12-17 06:00AM
May-08-17 06:00AM
Apr-04-17 08:41AM
Mar-31-17 06:11AM
06:00AM
Mar-27-17 06:00AM
Dec-28-16 04:06PM
Dec-13-16 04:08PM
Dec-02-16 04:11PM
Nov-22-16 01:04PM
Nov-18-16 11:50AM
Nov-15-16 06:00AM
Nov-14-16 04:12PM
Nov-07-16 08:00AM
Aug-12-16 06:00AM
Aug-11-16 04:27PM
Aug-01-16 06:00AM
Jun-06-16 12:12PM
May-17-16 06:00AM
May-16-16 05:17PM
May-05-16 06:00AM
Apr-05-16 11:33AM
10:27AM
China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The firm's product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products. The company was founded by Zhi Lin Li on January 28, 1999 and is headquartered in Haikou, China.